Regulatory Policy

Regulatory Policy

Portrait of a smiling man in front of a background featuring chemical structures and molecular models in green and blue hues.
MAPS founder Rick Doblin speaks to Big Think about the FDA’s rejection of MDMA therapy and the future of psychedelic treatments.